Fda

Cerebral Health fails FDA GMP inspection

Cerebral Health fails FDA GMP inspection

The US Food and Drug Administration (FDA) has issued a warning letter to Florida-based Cerebral Health, LLC, for failing to comply with Current Good Manufacturing Practice (CGMP).

Ullman & Mackay: Not happy

Dispatches from SupplySide East

NDI guidance could be 'gamechanger' for supplements trade

By Elaine Watson, Secaucus, New Jersey

Fears are mounting that the Food and Drug Administration’s (FDA’s) long-awaited guidance on new dietary ingredients (NDIs) could prove a “game changer” for the industry, and not in a good way.

FDA should allow for dietary supplements, says CRN

CRN: Phytosterol health claim should allow dietary supplements

By Stephen Daniells

The FDA’s proposed changes for a phytosterol-based coronary heart disease (CHD)-lowering health claim should allow for powdered dietary supplements containing free phytosterols, says the Council for Responsible Nutrition (CRN).

Dr Shao: GMP guidance is useful in parts but lacks detail

FDA GMP guidance “won’t provide all the answers”, says CRN

By Shane Starling

Freshly issued FDA GMP guidance for small-to-medium sized dietary supplement manufacturers regurgitates a lot of what has already been published in the regulation, but does bring fresh focus to matters such as expiration dates and ingredient supplier...

Signergy: Found to be contaminated in New Zealand

FDA takes hard line on erectile dysfunction supplement

By Shane Starling

In the same week the US Food and Drug Administration (FDA) announced an industry-backed crackdown on spiked weight loss, body building and sexual enhancement products, the agency issued an alert against a sulfoaildenafil-contaminated product called Man...

A transatlantic view of regulations and health claims

A transatlantic view of regulations and health claims

By Stephen Daniells

Should the FDA work to be more like EFSA? Speaking at the NutraIngredients Health Claims 2010 conference Andrew Shao said the two organisations are already very similar in the way they review scientific claims.

Selenium qualified cancer claims: FDA approved (with disclaimer)

Selenium qualified health claims are usable, says attorney

By Shane Starling

The legal counsel who represented Durk Pearson, Sandy Shaw and others in the recent case that forced the Food and Drug Administration (FDA) to alter three approved selenium health claims, says his clients and others will use the claims.

2009 review: FDA warning letters clampdown

2009 review: FDA warning letters clampdown

In 2008, the Food and Drug Administration (FDA) issued 44 warning letters with internet cancer claims being the primary target. In 2009, the agency upped the ante, issuing 73 letters, half of which targeted swine flu (H1N1) products. Washington DC-based...

Report reveals flaws in US food tracing system

Report reveals flaws in US food tracing system

By Rory Harrington

There are serious flaws in a US Government system to help federal agencies pinpoint plants implicated in outbreaks of food-borne illnesses, according to new report.

FDA cops (more) GMP criticism

FDA cops (more) GMP criticism

By Shane Starling

Insufficient inspection numbers, unclear ingredient identity testing and supplier audit requirements to meet Good Manufacturing Processes (GMPs), are some of the problems blighting the recently introduced regulation, says a Californian-based supplier.

FDA ‘motivates’ firms to correct violations

FDA ‘motivates’ firms to correct violations

By Lorraine Heller

A warning letter close-out process implemented this month by the US Food and Drug Administration (FDA) hopes to encourage firms to take corrective action – but so far even responses to warning letters are lacking.

Reformulated Hydroxycut back on shelves

Reformulated Hydroxycut back on shelves

By Lorraine Heller

The market-leading weight loss supplement Hydroxycut has been reformulated and re-launched in the United States, just months after being recalled for potentially causing liver damage.

Brain health ingredient switches from drug to supplement route

Brain health ingredient switches from drug to supplement route

By Lorraine Heller

A Canadian pharmaceutical firm is asking the US Food and Drug Administration (FDA) to approve a new supplement ingredient, which has demonstrated brain health benefits – one year after the firm withdrew its application for it to be approved as a drug.

Supplements and DSHEA under mass attack

Supplements and DSHEA under mass attack

By Lorraine Heller

The US dietary supplement industry is facing a massive media onslaught after recent recalls of harmful products have placed the sector and the law that regulates it under the spotlight.

General Mills Cheerios cereal is a drug, says FDA

General Mills Cheerios cereal is a drug, says FDA

By Lorraine Heller

General Mills has been told to change the marketing of its popular Cheerios whole grain cereal, as the health claims it currently uses classify it as an unapproved drug.

GMP inspections likely to start by fall, says FDA

Dispatches from Supply Side East

GMP inspections likely to start by fall, says FDA

By Lorraine Heller

Although all medium-sized dietary supplement manufacturers in the US will be required to meet new GMP regulations as of June this year, FDA has said it is unlikely to start inspections until fall. The agency’s manager of the Division of Dietary Supplements...

Supply Side East preview

Disptaches from Supply Side East

Supply Side East preview

By Lorraine Heller

Today is the first day of Supply Side East, one of the major east coast trade shows for the functional foods and supplements industries. Lorraine Heller takes a peek at the program and shares some thoughts about what to expect from the show.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All